ELTX Elicio Therapeutics, Inc.

NEUTRAL Impact: 4/10 EFFECT
Horizon weeks Filed Mar 17, 2026 Processed 2mo ago SEC 9999999995-26-000830
IPO/offering going effective
Latest settled — T+20d
ELTX ▼ -3.28% at T+20d
NEUTRAL call ✗ call lost -3.28% · α vs SPY -7.58% · entry $12.18 → $11.78
Next anchor: T+60d tomorrow
Last close $13.55 (close Jun 8) · +11.25% from $12.18 entry
Entry anchored
Mar 16, 03:59 PM ET
via Databento tick
T+1d
-4.11%
call -4.11% · α -2.71%
$11.68
settled 3mo ago
T+5d
-13.38%
call -13.38% · α -10.73%
$10.55
settled 3mo ago
T+20d
-3.28%
call -3.28% · α -7.58%
$11.78
settled 8w ago
T+60d
call — · α —
tomorrow

Price Chart

Loading chart...

Executive Summary

Elicio Therapeutics' shelf registration (Form S-3) has become effective, allowing the company to issue unspecified securities from time to time. This provides capital-raising flexibility but creates potential for future dilution.

Actionable Insight

Monitor for imminent securities offerings under this shelf registration, which could lead to stock dilution or downward price pressure. Absent an immediate offering, the impact is minimal.

Key Facts

  • Shelf registration (Form S-3) became effective on March 16, 2026
  • Registration allows Elicio Therapeutics to issue unspecified amounts of securities in one or more offerings
  • No immediate capital raise occurred; this is a procedural step enabling future offerings
  • Company previously known as Angion Biomedica Corp., renamed in 2014

Financial Impact

Potential future dilution depending on size and pricing of subsequent offerings

dilutionequitymarket_cap

Risk Factors

  • Future dilutive offerings could negatively impact existing shareholders
  • Market perception of equity overhang may suppress stock price

Market Snapshot

Exchange
Nasdaq

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-000830
Document: 9999999995-26-000830-index.html9999999995-26-000830
Document: 9999999995-26-000830.txt9999999995-26-000830
4 reports for ELTX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ELTX — sortable, filterable
Type Now
May 11, 2026
29d ago
8-K
NEUTRAL ★ 4/10
$10.55 $9.57▼ −9.29%▼ −9.37%$13.55 (+28.44%)
Mar 17, 2026
12w ago
EFFECT
NEUTRAL ★ 4/10
$12.18 $10.55▼ −13.38%▼ −10.73%$13.55 (+11.25%)
Mar 12, 2026
12w ago
Press Release
NEUTRAL ★ 5/10
$12.20 $10.85▼ −11.07%▼ −8.95%$13.55 (+11.07%)
Mar 2, 2026
14w ago
S-3/A
BEARISH ★ 6/10
$12.50 $12.90▼ −3.20%▼ −3.68%$13.55 (−8.40%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 6h 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access